💬
🤖
AI Support
24/7 online · instant AI reply
✕
📡 24/7 Live Updates

News Square

Global Crypto News · Real-time Aggregation

Fear & Greed
65
Greed (+3)
BTC $72,134 +2.3%
ETH $3,892 +1.8%
SOL $168 +4.2%
12h ago · Decrypt

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru

→
Flash 2026-10-21 18:18:57 · Bijing Flash

Helio Corp:提交200万股SEC备案

Helio Corp filed an SEC registration for 2 million shares, according to BiJie Network.

→
Flash 2026-10-21 18:18:50 · Bijing Flash

Helio Corp applies for Nasdaq listing under the ticker symbol 'HLEO'

Helio Corp has filed an application with the U.S. Securities and Exchange Commission (SEC) to list on the Nasdaq Capital Market under the ticker symbol 'HLEO', according to BiJie Network.

→
Flash 2026-10-21 18:17:14 · Bijing Flash

The long-to-short account ratio for ETH contracts is 2.71.

CoinWorld data: The ETHUSDT 4-hour long-short account ratio is 2.71, with more net long accounts than net short accounts. Compared with the same-caliber snapshot 24 hours ago, it is down 0.2944; compared with the same-caliber snapshot 7 days ago, it is down 0.0659.

→
Flash 2026-10-21 18:14:38 · Bijing Flash

NVIDIA's Jensen Huang unveils the OpenShell architecture to constrain AI agents

CoinWorld news, according to Cointelegraph, NVIDIA CEO Jensen Huang recently released the OpenShell architecture, aimed at setting limits for AI agents to prevent them from overstepping boundaries.

→
Flash 2026-10-21 18:13:36 · Bijing Flash

NVIDIA releases DSX POD AI factory reference design

CoinWorld news: NVIDIA CEO Jensen Huang unveiled the DSX POD AI factory reference design during his GTC Berlin keynote on October 21 (Beijing time). The product is built inside modular containers and is fully integrated and validated before delivery, with global deliveries expected to begin in early 2027. Huang said that compared with traditional data center deployments, DSX POD can cut the time from the start of deployment to token generation from six months to as little as 14 days, marking a transformation in the supply chain.

→
Flash 2026-10-21 18:11:36 · Bijing Flash

BNB Standard任命Alex Odagiu为CEO,启动BNB节点运营

CoinWorld news: BNB Standard has appointed Alex Odagiu as CEO and launched BNB node operations. The current BNC stock price is approximately $5.4, with each share holding BNB valued at about $7.10, and MNAV remains below 1.

→
Flash 2026-10-21 18:11:25 · Bijing Flash

NVIDIA expands its open model family, covering language, robotics, biopharmaceuticals, and quantum computing.

CoinWorld news: NVIDIA announced an expansion of its open model portfolio, covering areas such as vision and language, information retrieval, structured business data, biomedicine, robotics, and quantum computing, to help European enterprises and researchers develop customized applications using local data and deploy them on self-controlled infrastructure. The new products include the Nemotron 3.5 series of language and vision models, the Kumo model for structured business data analysis, the Cosmos world model for robot training and simulation, Alpamayo 2 Edge for autonomous driving, as well as BioNeMo RFD4-Proteina for protein design and the Ising model for quantum computing.

→
Flash 2026-10-21 18:10:58 · Bijing Flash

NVIDIA launches the Kumo open model to accelerate enterprise structured data analysis and forecasting.

CoinWorld news: Nvidia has launched Kumo, an open foundation model, development library, and tools aimed at enterprise structured data analysis, usable for forecasting, fraud risk scoring, and action recommendations, with the goal of reducing the cost and complexity of building separate machine learning pipelines for different tasks. Companies such as Cognite, Coinbase, Databricks, DoorDash, Revolut, and Tubi are among the first to use the Kumo model, and Snowflake customers have also adopted it for fields including advertising, energy, financial services, and retail.

→
Flash 2026-10-21 18:10:48 · Bijing Flash

NVIDIA expands its open model portfolio to help European enterprises

CoinWorld news, NVIDIA announced the expansion of its open model portfolio, covering areas such as vision and language, information retrieval, structured business data, biomedicine, robotics, and quantum computing, aiming to help European enterprises and researchers develop customized applications using local data and deploy them on autonomously controlled infrastructure. The new products include the Nemotron 3.5 series of language and vision models, the Kumo model (for structured business data analysis), the Cosmos world model (for robot training and simulation), Alpamayo 2 Edge (for autonomous driving), BioNeMo RFD4-Proteina (for protein design), and the Ising model (for quantum computing).

→
⚠️ Information is for reference only. Data from public sources, may have delays.